29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trial

Kyriazopoulou, Evdoxia;Kotsaki, Antigone;Safarika, Asimina;Poulakou, Garyfallia;Milionis, Haralampos;Metallidis, Simeon;Adamis, Georgios;Fragkou, Archontoula;Rapti, Aggeliki;Del Vecchio, Pierluigi;Kalomenidis, Ioannis;Kitzoglou, Danae;Angheben, Andrea;Kainis, Ilias;Iliopoulou, Konstantina;Serino, Francesco Saverio;Bakakos, Petros;Tzavara, Vassiliki;Ioannou, Sofia;Dagna, Lorenzo;Dimakou, Katerina;Tzatzagou, Glykeria;Chini, Maria;Bassetti, Matteo;Kotsis, Vasileios;Tsoukalas, George;Selmi, Carlo;Nikolakopoulou, Sofia;Samarkos, Michael;Doumas, Michael;Masgala, Aikaterini;Papanikolaou, Ilias;Argyraki, Aikaterini;Akinosoglou, Karolina;Symbardi, Styliani;Panagopoulos, Periklis;Dalekos, George N.;Liesenfeld, Oliver;Sweeney, Timothy E.;Khatri, Purvesh;Giamarellos-Bourboulis, Evangelos J.

2025-01-01